-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
-
Summary
-
Verrica Pharmaceuticals Inc. quarterly/annual General and Administrative Expense history and growth rate from Q1 2017 to Q2 2023.
- Verrica Pharmaceuticals Inc. General and Administrative Expense for the quarter ending June 30, 2023 was $5.94M, a 14.8% increase year-over-year.
- Verrica Pharmaceuticals Inc. General and Administrative Expense for the twelve months ending June 30, 2023 was $17.4M, a 25.8% decline year-over-year.
- Verrica Pharmaceuticals Inc. annual General and Administrative Expense for 2022 was $17.4M, a 35.5% decline from 2021.
- Verrica Pharmaceuticals Inc. annual General and Administrative Expense for 2021 was $27M, a 10.1% increase from 2020.
- Verrica Pharmaceuticals Inc. annual General and Administrative Expense for 2020 was $24.5M, a 67.4% increase from 2019.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Growth (%)